News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
399 Results
Type
Article (10)
Press Release (389)
Section
Business (73)
Deals (15)
Drug Development (53)
FDA (9)
Job Trends (8)
News (152)
Policy (9)
Tag
Alliances (14)
Alzheimer's disease (1)
Approvals (9)
Best Places to Work (5)
Clinical research (49)
COVID-19 (2)
Data (5)
Diagnostics (1)
Earnings (31)
Events (103)
FDA (14)
Healthcare (25)
Infectious disease (2)
IPO (3)
Job creations (3)
Legal (3)
Medical device (2)
Medtech (2)
Mergers & acquisitions (13)
Neuroscience (4)
NextGen: Class of 2026 (6)
Non-profit (2)
Pain (2)
People (28)
Phase I (12)
Phase II (23)
Phase III (20)
Pipeline (3)
Policy (1)
Preclinical (5)
Real estate (1)
Regulatory (9)
Spinal muscular atrophy (1)
Startups (5)
Date
Last 7 days (1)
Last 30 days (1)
Last 365 days (26)
2026 (1)
2025 (27)
2024 (26)
2023 (68)
2022 (48)
2021 (54)
2020 (23)
2019 (25)
2018 (4)
2017 (8)
2016 (5)
2015 (3)
2014 (15)
2013 (18)
2012 (8)
2011 (15)
2010 (19)
Location
Asia (8)
California (12)
Europe (50)
Illinois (1)
Indiana (23)
Japan (1)
Massachusetts (2)
New Jersey (14)
North Carolina (1)
Northern California (1)
Pennsylvania (1)
Southern California (9)
United States (53)
399 Results for "neurelis".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Neurelis Provides Business Update Highlighting Transformational 2025 Results
January 13, 2026
·
9 min read
Press Releases
NEURELIS TO PRESENT CLINICAL DATA AT AMERICAN EPILEPSY SOCIETY ANNUAL MEETING
December 8, 2025
·
12 min read
Press Releases
NEURELIS TO PARTICIPATE IN SOFIE’S JOURNEY EPILEPSY AWARENESS DAY AND EDUCATION EXPO AT DISNEYLAND® RESORT
November 11, 2025
·
7 min read
Press Releases
Neurelis to Highlight Data from a Study of Diazepam Nasal Spray in Pediatric Patients at the Child Neurology Society Annual Meeting
October 9, 2025
·
8 min read
Press Releases
NEURELIS TO PRESENT STUDY OF NRL-1049, A RHO KINASE (ROCK) INHIBITOR WITH POTENTIAL TO TREAT SYMPTOMATIC CEREBRAL CAVERNOUS MALFORMATIONS (CCM), AT ANNUAL CCM MEETING
November 7, 2025
·
7 min read
Press Releases
NEURELIS WILL HIGHLIGHT ANALYSES OF SEIZURE TREATMENT WITH DIAZEPAM NASAL SPRAY AT THE AMERICAN ACADEMY OF NEUROLOGY ANNUAL MEETING
April 8, 2025
·
8 min read
Press Releases
NEURELIS ANNOUNCES FDA APPROVAL FOR IMMEDIATE USE SEIZURE MEDICATION VALTOCO® (DIAZEPAM NASAL SPRAY) IN AGES 2 TO 5
April 16, 2025
·
7 min read
Press Releases
NEURELIS PRESENTS STUDIES ON SEIZURE CLUSTERS AT THE AMERICAN EPILEPSY SOCIETY ANNUAL MEETING
December 9, 2024
·
11 min read
Biotech Beach
NEURELIS ANNOUNCES TWO POSTER PRESENTATIONS AT THE 76TH ANNUAL MEETING OF THE AMERICAN ACADEMY OF NEUROLOGY
Neurelis, Inc. will present a poster on VALTOCO® (diazepam nasal spray) for the treatment of episodes of frequent seizure activity (i.e., seizure clusters) in patients with epilepsy ages 6 to 65 years, describing the time to treatment across different subpopulations.
April 11, 2024
·
8 min read
Biotech Beach
NEURELIS ANNOUNCES PRESENTATIONS AT THE AMERICAN EPILEPSY SOCIETY ANNUAL MEETING
Neurelis, Inc., today announced that the company will present six poster presentations at the American Epilepsy Society (AES) Annual Meeting held in Orlando, Florida from December 1 – 5, 2023.
December 1, 2023
·
11 min read
1 of 40
Next
